BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//jEvents 2.0 for Joomla//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VTIMEZONE
TZID:America/New_York
X-LIC-LOCATION:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:19700308T020000
RRULE:FREQ=YEARLY;BYMONTH=3;BYDAY=2SU
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:19701101T020000
RRULE:FREQ=YEARLY;BYMONTH=11;BYDAY=1SU
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
UID:767bf8755c1bb8baddce50ff5bfa90031
CATEGORIES:SBCA Events
SUMMARY:CBA for U.S. Regulatory Impact Statements
DESCRIPTION:
CBA for U.S. Regulatory Impact Statements (Co-sponsore
d by the Society for Risk Analysis Econo
mics and Benefits Analysis Specialty Group)
Benefit-cost ana
lysis is used around the world to assess regulatory impacts. This workshop
introduces the use of Benefit-Cost Analysis for Regulatory Impact Analyses
(RIAs) in the Federal government. The topics will include issues of identif
ying the market failure, establishing the correct baseline, choosing the po
licy options, estimating benefits, estimating costs, and identifying transf
ers. The focus will on analyses of U.S. health, and safety regulations issu
ed by the Department of Health and Human Services, with further examples fr
om the Environmental Protection Agency (EPA) in the last two decades, but t
he concepts and practices we discuss are equally applicable to analyses con
ducted in other policy areas and in other countries or at a sub-national le
vel. The workshop will be structured as an overarching presentation with ex
amples from past RIAs used as practical example to be discussed by the part
icipants.
This workshop is intended for both econom
ists and other practitioners who have a working knowledge of Benefit-Cost A
nalysis and the general concept of measuring welfare effects. This working
knowledge will then be applied to the Regulatory Impact Analysis context. T
he presenters are seasoned practitioners with substantial experience in con
ducting these analyses for federal regulatory actions
About the presenters:- Aliya Sassi earned her
PhD in Economics at the University of New Hampshire. She is a Senior Econom
ist at the U.S. FDA where she serves as a subject matter expert, project le
ad, and economic consultant to top level management and develops benefit-co
st analyses of FDA regulations. Her areas of expertise include regulatory i
mpact analysis, food safety, international trade, and economic modeling. Pr
eviously, she has detailed as a Senior Economist at the U.S. Department of
Health and Human Services and as an Assistant Director of Economics at FDA
and taught economics at the University of New Hampshire.
- Lizzi Quin earned her PhD in Economics at Michigan State Universi
ty. At the FDA she has developed benefit-cost analyses for drug, medical de
vice, animal drug, biologics, and tobacco regulations. Previously, she has
detailed at the U.S. Department of Health and Human Services. She is curren
tly an Assistant Director of Economics at FDA and oversees benefit-costs an
alyses covering all FDA-regulated products.
- Chris Doc
kins earned his PhD in Economics at Duke University, focusing on Env
ironmental Economics and Public Finance. At the EPA he has helped develop b
enefit-cost analyses for EPA's air, water, hazardous waste, and chemicals r
egulations, performed and published research on related topics, and directe
d a division of scientists in EPA's National Center for Environmental Econo
mics. He also teaches benefit-cost analysis at Johns Hopkins University and
environmental economics at the University of Maryland.
- Charles Griffiths earned his PhD in Economics at the University of
Maryland. At the EPA he has worked on the estimation of the social cost of
carbon and helped develop benefit-cost analysis for EPA’s air, water, and
chemical regulation. He has conducted research on climate change, health ri
sks, water regulations, air regulations, and voluntary programs and was a S
enior Economist for Environment, Energy, and Agriculture at the President's
Council of Economic Advisors. He also teaches benefit-cost analysis at Joh
ns Hopkins University and environmental economics at the University of Mary
land.
- Aaron Kearsley did his graduate work in E
conomics at the University of North Carolina, Chapel Hill and the Universit
y of Nevada, Las Vegas. Aaron is a Senior Economist at the U.S. Department
of Health and Human Services within the office of the Assistant Secretary f
or Planning and Evaluation, which reviews all regulatory impact analyses fo
r the Department and its agencies prior to publication. He was previously a
n economist at FDA, specializing in drug and tobacco regulations.
Date and Times:
October 13 & 14, 11:00 am -1:0
0 pm US eastern time
Fee:
Regular registration: $300 per person
Low-and middl
e-income country residents: $100 per person (Based on
World Bank Classification)
Students (fulltime)
: $50 per person
Registration Open
Please Note
Registration will be capped. Please register soon to ensure your
spot. Check back periodically for additional information and offerings.
Supporting SBCA
It is generous donations
from people like you who make these offerings possible. Please consider j
oining our efforts to strengthen the benefit-cost analysis profession throu
gh membership and/or by m
aking a donation.
DTSTAMP:20240328T140621
DTSTART;TZID=America/New_York:20211013T110000
DTEND;TZID=America/New_York:20211014T130000
SEQUENCE:0
TRANSP:OPAQUE
END:VEVENT
END:VCALENDAR